Patients with first-year nadir testosterone consistently > @ nmol/L had significantly higher risks of dying as a result of disease ( @ to @ nmol/L : hazard ratio -LSB- HR -RSB- , @ ; @ % CI , @ to @ ; > @ nmol/L : HR , @ ; @ % CI , @ to @ ) and developing hormone resistance ( @ to @ nmol/L : HR , @ ; @ % CI , @ to @ ; @ nmol/L : HR , @ ; @ % CI , @ to @ ) .